Premenstrual Syndrome Clinical Trial
Official title:
Androgen Hormones in PMDD
This study will evaluate the effectiveness of flutamide in reducing symptoms of premenstrual dysphoric disorder.
Premenstrual dysphoric disorder (PMDD) is a condition that affects about 5% of menstruating
women. Women with PMDD experience serious emotional and physical disturbances, which may
include depression, tension, irritability, anger, anxiety, and sleep and appetite problems.
Symptoms of PMDD are directly linked with the menstrual cycle, generally beginning in the
latter half of the cycle and ending around the start of the next cycle. If left unmanaged,
PMDD may interfere with a woman's ability to carry out normal day-to-day functioning. Current
treatments for PMDD include medications, psychotherapy, and nutritional modifications.
Flutamide, a medication that blocks the action of testosterone and other mood-influencing
hormones, may be helpful in alleviating symptoms of PMDD. This study will evaluate the
effectiveness of flutamide in reducing symptoms of premenstrual dysphoric disorder.
This two-phase study will last a total of 4 months and will include 7 study visits. Phase 1
will last 2 months and will include Visits 1 through 3. During Phase 1, participants will
keep a daily record of symptoms, participate in a diagnostic interview, and undergo a medical
history review, a physical exam, and screening laboratory tests. Eligible participants will
then enter Phase 2, the treatment phase of the study.
During the treatment phase, participants will be randomly assigned to take flutamide or
placebo for 2 months. Study visits will occur every 2 weeks and will include Visits 4 through
7. These visits will include discussion of side effects, symptom rating, and laboratory tests
to check for pregnancy and any side effects related to liver function, blood counts, or blood
chemistry. At the end of treatment with flutamide or placebo, participants will have the
option of receiving treatment with sertraline, an antidepressant known to be effective for
many women with PMDD. Sertraline will be given during the 2 premenstrual weeks for two
cycles. If participants have already unsuccessfully tried sertraline for PMDD treatment, an
alternative treatment can be attempted.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02481973 -
The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome
|
Phase 2 | |
| Completed |
NCT00195559 -
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
|
Phase 3 | |
| Completed |
NCT00048854 -
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
|
Phase 1/Phase 2 | |
| Completed |
NCT00965562 -
Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
|
N/A | |
| Completed |
NCT05349344 -
Effect of Aerobic Exercise on Premenstrual Syndrome Symptoms (PMS).
|
N/A | |
| Recruiting |
NCT06146673 -
A Multidimensional Study of Premenstrual Syndrome and Body Image
|
||
| Recruiting |
NCT05836454 -
The Soft Tissue Mobilization Techniques on PMS
|
N/A | |
| Completed |
NCT05499000 -
The Effect of Emotional Freedom Technique on Premenstrual Syndrome
|
N/A | |
| Recruiting |
NCT06144073 -
The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome
|
N/A | |
| Recruiting |
NCT06105567 -
The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress
|
N/A | |
| Completed |
NCT03298607 -
The Impact of Serelys PMS on Symptoms of PMS
|
Phase 3 | |
| Recruiting |
NCT06176313 -
Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms
|
N/A | |
| Recruiting |
NCT02562053 -
Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
|
Phase 3 | |
| Completed |
NCT00229346 -
Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients
|
N/A | |
| Completed |
NCT00516113 -
A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria
|
Phase 4 | |
| Completed |
NCT04901598 -
Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome
|
||
| Completed |
NCT05692479 -
Premenstrual Syndrome and Physical Activity Self-Worth
|
||
| Recruiting |
NCT05665972 -
Effects of Mandala Coloring on Premenstrual Syndrome
|
N/A | |
| Not yet recruiting |
NCT06052722 -
The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders
|
N/A | |
| Completed |
NCT05556252 -
The Effect of Hydrogen-rich Water on Premenstrual Symptoms and Quality of Life
|
N/A |